In the current study, participants with hypertension, hyperlipidaemia, diabetes, and history of statin and calcium channel blocker use had significantly higher TNF-α levels compared to participants without these health conditions indicating an increased level of inflammation. The gene discussed is TNF; the disease is hyperlipidemia.